25.29
price down icon2.24%   -0.58
after-market Handel nachbörslich: 25.29
loading

Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.04%
0.73
0.695 1.175 3.191 2.498
Operating Expenses
1.82%
64.59
63.43 57.00 55.32 48.81
Benefits Costs and Expenses
1.82%
64.59
63.43 19.99 55.32 48.81
Costs And Expenses
1.82%
64.59
63.43 57.20 55.32 48.81
Operating Income/Loss
1.78%
-63.86
-62.74 -56.03 -52.13 -46.32
Income/Loss From Continuing Operations Before Tax
18.70%
-63.86
-53.80 -18.81 -52.13 -35.84
Income/Loss From Continuing Operations After Tax
5.21%
-56.60
-53.80 -7.271 -42.12 -35.84
Net Income/Loss
5.21%
-56.60
-53.80 -47.09 -42.12 -35.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.01%
0.0664
0.0664 0.000658 0.0663 0.066
Diluted Average Shares
0.01%
0.0664
0.0664 0.000658 0.0663 0.066
Basic Earnings Per Share
4.94%
-0.85
-0.81 -0.71 -0.64 -0.54
Diluted Earnings Per Share
4.94%
-0.85
-0.81 -0.71 -0.64 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.32
price up icon 2.95%
$86.70
price up icon 2.23%
$31.77
price up icon 3.59%
$102.21
price up icon 3.64%
$147.28
price up icon 2.27%
biotechnology ONC
$335.16
price down icon 1.63%
Kapitalisierung:     |  Volumen (24h):